CG Oncology, Inc. CGON
Set alert
64.68 USD +1.21 +1.91%
At close · Oct 30
64.68 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
60.63 Day range 65.55
37.37 52-week range 80.68
- YTD
- +55.78%
- 1 year
- +52.30%
- Open
- 63.02
- Prev close
- 63.47
- Mkt cap
- 5.73B
- Vol
- 870.33K
- Avg vol
- 868.03K
- EPS
- -2.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 60.63
- High
- 65.55
- Forward P/E
- -21.41
- Beta
- 0.28
- Short ratio
- 8.13
- Inst. own
- 113.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 13, 2026
- 50-d avg
- 69.69
- 200-d avg
- 65.86
- 1y target
- 91.08
Ownership
Held by insiders 0.23%
Held by institutions 113.45%
Float held by institutions 113.71%
Institutions 344
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 9.61% | 8,514,590 | 550.72M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 7.46% | 6,616,899 | 427.98M | Jun 29, 2026 |
| Decheng Capital LLC | 7.19% | 6,371,669 | 412.12M | Jun 29, 2026 |
| Blackrock Inc. | 7.06% | 6,256,288 | 404.66M | Jun 29, 2026 |
| Wellington Management Group, LLP | 6.01% | 5,324,751 | 344.40M | Jun 29, 2026 |
| FMR, LLC | 4.69% | 4,161,493 | 269.17M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 3.23% | 2,860,428 | 185.01M | Jul 30, 2026 |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 2.90% | 2,574,868 | 166.54M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.69% | 2,383,134 | 154.14M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.16% | 1,911,075 | 123.61M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.94% | 1,720,068 | 111.25M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.74% | 1,541,674 | 99.72M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| KUAN ARTHUR | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 11, 2026 | 198,916 |
| LIU BRIAN GUAN-CHYUN M.D. | Director | Purchase | Jun 24, 2026 | 0 |
| MULAY JAMES J. | Director | Conversion of Exercise of derivative security | Jul 9, 2026 | 0 |
| POST LEONARD E | Director | Conversion of Exercise of derivative security | Oct 14, 2026 | 0 |
| SONG HONG FANG | Director | Sale | Sep 2, 2025 | 0 |
Held by funds
151 US ETFs and mutual funds hold CGON · largest positions